Anca Chelariu-Raicu (Anca Chelariu)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Endometrial Cancer

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jibran Ahmed, Carlos Torrado, Anca Chelariu-Raicu, Sun-Hee Kim, Jordi Rodon Ahnert
Fusion Challenges in Solid Tumors: Shaping the Landscape of Cancer Care in Precision Medicine. JCO precision oncology 8 (2024)
Anca Chelariu-Raicu, Sven Mahner, Kathleen Nadine Moore, Domenica Lorusso, Robert L Coleman
Integrating antibody drug conjugates in the management of gynecologic cancers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Anca Chelariu-Raicu, Sarina A Piha-Paul, Mariana Chavez-MacGregor, Jason Johnson, Raymond Sawaya, Mary Frances McAleer, Alissa Nguyen, Audrey Hartnett, Apostolia M Tsimberidou, Funda Meric-Bernstam, Ecaterina E Dumbrava
Multidisciplinary Care of a Large Brain Metastasis in a Patient with Hormone-Receptor-Positive Breast Cancer with Ataxia-Telangiectasia Mutation. Journal of immunotherapy and precision oncology 6 (3) (2023)
Anca Chelariu-Raicu, Sven Mahner, Kathleen Nadine Moore, Domenica Lorusso, Robert L Coleman
Integrating antibody drug conjugates in the management of gynecologic cancers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Anca Chelariu-Raicu, Fabian Trillsch, Alexander Burges, Bastian Czogalla, Anna Hester, Rahel Wuerstlein, Nadia Harbeck, Sven Mahner
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Anca Chelariu-Raicu, Sven Mahner, Kathleen Nadine Moore, Domenica Lorusso, Robert L Coleman
Integrating antibody drug conjugates in the management of gynecologic cancers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Anca Chelariu-Raicu, Eva Holley, Doris Mayr, Frederick Klauschen, Fabienne Wehweck, Miriam Rottmann, Mirjana Kessler, Till Kaltofen, Bastian Czogalla, Fabian Trillsch, Sven Mahner, Elisa Schmoeckel
A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 32 (5) (2022)
Anca Chelariu-Raicu, Lauren P Cobb, David M Gershenson
Fertility preservation in rare ovarian tumors. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 31 (3) (2022)
Shannon Neville Westin, Marilyne Labrie, Jennifer K Litton, Aurora S Blucher, Yong Fang, Christopher P Vellano, Joseph R Marszalek, Ningping Feng, XiaoYan Ma, Allison L Creason, Bryan Fellman, Ying Yuan, Sanghoon Lee, Tae-Beom Kim, Jinsong Liu, Anca Chelariu-Raicu, Tsun Hsuan Chen, Nashwa Kabil, Pamela T Soliman, Michael Frumovitz, Katheleen M Schmeler, Amir A Jazaeri, Karen H Lu, Rashmi K Murthy, Larissa A Meyer, Charlotte C Sun, Anil K Sood, Robert L Coleman, Gordon B Mills
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Brian M Slomovitz, Anca Chelariu-Raicu, Kathleen M Schmeler, Karen H Lu, David M Gershenson, Judith Wolf, Robert L Coleman
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 30 (11) (2020)
Anca Chelariu-Raicu, Charles F Levenback, Brian M Slomovitz, Judith Wolf, Diane C Bodurka, John J Kavanagh, Christopher Morrison, David M Gershenson, Robert L Coleman
Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 30 (11) (2020)
Anca Chelariu-Raicu, Graziela Zibetti Dal Molin, Robert L Coleman
The new world of poly-(ADP)-ribose polymerase inhibitors (PARPi) used in the treatment of gynecological cancers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 30 (10) (2020)
Mark Seungwook Kim, Shaolin Ma, Anca Chelariu-Raicu, Carola Leuschner, Hector W Alila, Sanghoon Lee, Robert L Coleman, Anil K Sood
Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer. Molecular cancer therapeutics 19 (11) (2020)